Journal watch 29/03/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Journal watch 29/03/2023
STEP 8: Greater weight loss for once-weekly semaglutide vs daily liraglutide
Saxenda approved for the treatment of obesity in adolescents
Liraglutide successfully targets fat that can endanger heart health
Vigorous-intensity plus liraglutide maintains long-term weight loss
Brain response to liraglutide may inform future treatments
IBT and liraglutide show positive results for weight loss